AAAAAA

   
Results: 1-9 |
Results: 9

Authors: BUCKHEIT RW HOLLINGSHEAD M SINSON S FLIAKASBOLTZ V PALLANSCH LA ROBERSON J DECKER W ELDER C BORGEL S BONOMI C SHORES R SIFORD T MALSPEIS L BADER JP
Citation: Rw. Buckheit et al., EFFICACY, PHARMACOKINETICS, AND IN-VIVO ANTIVIRAL ACTIVITY OF UC781, A HIGHLY POTENT, ORALLY BIOAVAILABLE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR OF HIV TYPE-1, AIDS research and human retroviruses, 13(9), 1997, pp. 789-796

Authors: BUCKHEIT RW SNOW MJ FLIAKASBOLTZ V KINJERSKI TL RUSSELL JD PALLANSCH LA BROUWER WG YANG SS
Citation: Rw. Buckheit et al., HIGHLY POTENT OXATHIIN CARBOXANILIDE DERIVATIVES WITH EFFICACY AGAINST NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 831-837

Authors: BUCKHEIT RW FLIAKASBOLTZ V RUSSELL JD SNOW M PALLANSCH LA YANG SS BADER JP KHAN TN ZANGER M
Citation: Rw. Buckheit et al., A DIARYLSULPHONE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR WITH AUNIQUE SENSITIVITY PROFILE TO DRUG-RESISTANT VIRUS ISOLATES, Antiviral chemistry & chemotherapy, 7(5), 1996, pp. 243-252

Authors: CUSHMAN M GOLEBIEWSKI WM GRAHAM L TURPIN JA RICE WG FLIAKASBOLTZ V BUCKHEIT RW
Citation: M. Cushman et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF CERTAIN ALKENYLDIARYLMETHANES AS ANTI-HIV-1 AGENTS WHICH ACT AS NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS, Journal of medicinal chemistry, 39(16), 1996, pp. 3217-3227

Authors: YANG SS FLIAKASBOLTZ V BADER JP BUCKHEIT RW
Citation: Ss. Yang et al., CHARACTERISTICS OF A GROUP OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS WITH STRUCTURAL DIVERSITY AND POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY, Leukemia, 9, 1995, pp. 75-85

Authors: BUCKHEIT RW FLIAKASBOLTZ V DECKER WD ROBERSON JL STUP TL PYLE CA WHITE EL MCMAHON JB CURRENS MJ BOYD MR BADER JP
Citation: Rw. Buckheit et al., COMPARITIVE ANTI-HIV EVALUATION OF DIVERSE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITOR-RESISTANT VIRUS ISOLATES DEMONSTRATES THE EXISTENCE OF DISTINCT PHENOTYPIC SUBGROUPS, Antiviral research, 26(2), 1995, pp. 117-132

Authors: BUCKHEIT RW KINJERSKI TL FLIAKASBOLTZ V RUSSELL JD STUP TL PALLANSCH LA BROUWER WG DAO DC HARRISON WA SCHULTZ RJ BADER JP YANG SS
Citation: Rw. Buckheit et al., STRUCTURE-ACTIVITY AND CROSS-RESISTANCE EVALUATIONS OF A SERIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC COMPOUNDS RELATED TO OXATHIIN CARBOXANILIDE, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2718-2727

Authors: BUCKHEIT RW FLIAKASBOLTZ V YEAGYBARGO S WEISLOW O MAYERS DL BOYER PL HUGHES SH PAN BC CHU SH BADER JP
Citation: Rw. Buckheit et al., RESISTANCE TO 1-[(2-HYDROXYETHOXY)METHYL]-6-(PHENYLTHIO)THYMINE DERIVATIVES IS GENERATED BY MUTATIONS AT MULTIPLE SITES IN THE HIV-1 REVERSE-TRANSCRIPTASE, Virology, 210(1), 1995, pp. 186-193

Authors: BUCKHEIT RW FLIAKASBOLTZ V DECKER WD ROBERSON JL PYLE CA WHITE EL BOWDEN BJ MCMAHON JB BOYD MR BADER JP NICKELL DG BARTH H ANTONUCCI TK
Citation: Rw. Buckheit et al., BIOLOGICAL AND BIOCHEMICAL ANTI-HIV ACTIVITY OF THE BENZOTHIADIAZINE CLASS OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS, Antiviral research, 25(1), 1994, pp. 43-56
Risultati: 1-9 |